Ambeed.cn

首页 / / / / DM4

DM4 {[allProObj[0].p_purity_real_show]}

货号:A348562 同义名: Maytansinoid DM 4

DM4 是一种微管抑制剂,通过与微管蛋白结合并抑制微管组装,常作为抗体偶联药物(ADC)的细胞毒性载荷(payload),在癌症治疗领域具有重要应用。

HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
DM4 化学结构 CAS号:796073-69-3
DM4 化学结构
CAS号:796073-69-3
DM4 3D分子结构
CAS号:796073-69-3
DM4 化学结构 CAS号:796073-69-3
DM4 3D分子结构 CAS号:796073-69-3
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

DM4 纯度/质量文件 产品仅供科研

货号:A348562 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >

DM4 生物活性

描述 Tubulin normally undergoes a cycle of detyrosination/tyrosination on the carboxy terminus of its alpha-subunit and this results in subpopulations of tyrosinated tubulin and detyrosinated tubulin[1]. Maytansinoid DM4 is a thiol-containing maytansine derivative with highly potent cytotoxicity. Maytansinoid DM4 is a tubulin inhibitor, inhibits the assembly of microtubules by binding to tubulin, with a linker structure can create an antibody-drug conjugate (ADC). Maytansine is a natural benzoansamacrolide product isolated from the bark of the African shrub Maytenus ovatus. Maytansine binds to the same site on tubulin as the vinca alkaloids, with similar in vitro inhibition constants, but is a more-potent cytotoxin[2]. Maytansinoid DM1 and DM4 inactivated CYP3A from human liver microsomes with K(i)/k(inact) values of 4. 8 ± 0. 9 μM/0. 035 ± 0. 002 min(-1) and 3. 3 ± 0. 2 μM/0. 114 ± 0. 002 min(-1), respectively. DM1 and DM4 inactivated recombinant CYP3A4 with K(i)/k(inact) values of 3. 4 ± 1. 0 μM/0. 058 ± 0. 005 min(-1) and 1. 4 ± 0. 3 μM/0. 117 ± 0. 006 min(-1), respectively[3]. Although S-methyl-DM1 and S-methyl-DM4 inhibited polymerization more weakly than maytansine, at 100 nmol/L they suppressed dynamic instability more strongly than maytansine (by 84% and 73%, respectively, compared with 45% for maytansine). Both maytansine and S-methyl-DM1 bound to tubulin with similar K(D) values (0. 86 ± 0. 2 and 0. 93 ± 0. 2 μmol/L, respectively)[4].

DM4 细胞实验

Cell Line
Concentration Treated Time Description References
Microtubule protein 100 nmol/L 40 minutes To evaluate the effect of DM4 on microtubule dynamic instability, results showed that DM4 significantly suppressed microtubule dynamic instability, reducing the shortening rate by 56% and dynamicity by 73%. Mol Cancer Ther. 2010 Oct;9(10):2689-99
Microtubule protein 0 – 20 μmol/L 45 minutes To evaluate the inhibitory effect of DM4 on microtubule polymerization, results showed that DM4 inhibited microtubule polymerization at 1.7 ± 0.4 μmol/L. Mol Cancer Ther. 2010 Oct;9(10):2689-99
NXS2 cells 3nM 72 hours To evaluate the effect of DM4 on PD-L1 expression, results showed that DM4 significantly upregulated the surface expression of PD-L1. J Transl Med. 2025 Apr 11;23(1):431
NXS2 cells 5nM 72 hours To assess the ability of DM4 to induce immunogenic cell death (ICD), results showed that DM4 significantly upregulated the expression of calreticulin, HSP70, and HSP90. J Transl Med. 2025 Apr 11;23(1):431
NXS2 CTRL and NXS2 hLGALS3BP cells 0.00064nM to 250nM 72 hours To evaluate the cytotoxic effect of DM4 on neuroblastoma cells, results showed that DM4 exhibited potent cytotoxic activity with an IC50 in the nanomolar range (0.32 nM). J Transl Med. 2025 Apr 11;23(1):431

DM4 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
CB-17/SCID mice END(K)265 xenograft model Intravenous injection 5 mg/kg Once weekly for two doses IMGN853 showed significant tumor growth inhibition (p<0.01) and complete tumor resolution Mol Cancer Ther. 2018 May;17(5):1003-1011
BALB/c nude mice HT-29, HCT116 and HCT15 xenograft models Intravenously 5 and 10 mg/kg Three injections, every 3 days Evaluate the antitumor efficacy of T4H11-DM4 in xenograft models, complete tumor regression was achieved at doses of 5 and 10 mg/kg in HT-29 and HCT116 tumor models Mol Oncol. 2019 Sep;13(9):1855-1873
Mice A375-MA1 xenograft model Intravenous injection 6.0-6.7 μg Single dose, observed for 120 hours To evaluate the pharmacokinetics and tumor uptake of [89Zr]Zr-DFO-1959-sss/DM4 in the A375-MA1 xenograft model Mol Pharm. 2023 Jun 5;20(6):3241-3248
Nude mice GBM patient-derived xenograft model Intravenous injection 10 mg/kg Twice weekly for a total of three injections Evaluate the antitumor activity of 1959-sss/DM4 in GBM xenograft model Mol Oncol. 2023 Aug;17(8):1460-1473
NOD/SCID/IL-2Rg(null) mice and nude mice PDX and CDX models Tail vein injection 5 mg/kg and 10 mg/kg Once every three days for a total of three doses Anti-DOG1-DM4-ADC significantly inhibited tumor growth Front Immunol. 2023 Jan 26;14:1051506
A/J mice Neuroblastoma model Intravenous injection 10 mg/kg Twice weekly, three total injections To evaluate the antitumor activity of anti-LGALS3BP ADC in a neuroblastoma model, results showed that ADC significantly shrank hLGALS3BP-expressing tumors and improved survival. J Transl Med. 2025 Apr 11;23(1):431

DM4 参考文献

[1] L Lafanechère, D Job. The third tubulin pool. Neurochem Res. 2000 Jan;25(1):11-8.

[2] Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337.

[3] John A Davis 1, Dan A Rock, et al. In vitro characterization of the drug-drug interaction potential of catabolites of antibody-maytansinoid conjugates. Drug Metab Dispos. 2012 Oct;40(10):1927-34.

[4] Manu Lopus, Emin Oroudjev,et al. Maytansine and cellular metabolites of antibody-maytansinoid conjugates strongly suppress microtubule dynamics by binding to microtubules. Mol Cancer Ther. 2010 Oct;9(10):2689-99.

DM4 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.28mL

0.26mL

0.13mL

6.41mL

1.28mL

0.64mL

12.81mL

2.56mL

1.28mL

DM4 技术信息

CAS号796073-69-3
分子式C38H54ClN3O10S
分子量 780.37
SMILES Code C[C@]1([C@H](CC(N(C(C=C2C=C3OC)=C3Cl)C)=O)OC([C@H](C)N(C)C(CCC(C)(S)C)=O)=O)[C@H]([C@@H]([C@](OC4=O)([H])C[C@]([C@](/C=C/C=C(C)/C2)([H])OC)(N4)O)C)O1
MDL No. MFCD28144516
别名 Maytansinoid DM 4
运输蓝冰
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry, 2-8°C

溶解方案

DMSO: 105 mg/mL(134.55 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
方案 三
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。